Pathophysiology of saphenous vein graft failure: A brief overview of interventions

Current Opinion in Pharmacology

Volumn 12, Issue 2, 2012, Pages 114-120

  Shukla, Nilima ^a   Jeremy, Jamie Y ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIOXIDANT; CLOPIDOGREL; COLLAGEN; CYTOCHALASIN D; CYTOSTATIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EDIFOLIGIDE; ELASTIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; FIBROBLAST GROWTH FACTOR; ILOPROST; MATRIX METALLOPROTEINASE; NITRIC OXIDE; PACLITAXEL; PHOSPHODIESTERASE INHIBITOR; PLATELET DERIVED GROWTH FACTOR; PROSTACYCLIN; RAPAMYCIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SELECTIN; SOMATOMEDIN; THROMBOXANE SYNTHASE INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE; XANTHINE OXIDASE;

ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROGENESIS; CELL PROLIFERATION; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; DACRON VASCULAR PROSTHESIS; DRUG EFFECT; DRUG ELUTING STENT; EXTERNAL SHEATH; GENE TRANSFER; GRAFT FAILURE; GRAFT OCCLUSION; GRAFT PATENCY; HUMAN; IN-STENT RESTENOSIS; LEUKOCYTE ADHERENCE; NONHUMAN; OFF PUMP CORONARY SURGERY; OXIDATIVE STRESS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RISK FACTOR; SAPHENOUS VEIN GRAFT; SMOOTH MUSCLE FIBER; STENT; SURGICAL EQUIPMENT; SURGICAL TECHNIQUE; THROMBOCYTE ADHESION; VASCULAR SMOOTH MUSCLE; VEIN GRAFT DISEASE;

EID: 84861692321     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2012.01.001     Document Type: Review

References (50)

1. J.G. Motwani, and E.J. Topol Aortocoronary saphenous vein graft disease. Pathogenesis, predisposition and prevention Circulation 97 1998 916 931
2. R. Favaloro Critical analysis of coronary artery bypass graft surgery: a 30 year journey J Am Coll Cardiol 31 1998 1B 63B
3. J.Y. Jeremy, P. Gadsdon, and N. Shukla On the biology of saphenous vein grafts fitted with external synthetic sheaths and stents Biomaterials 28 2007 895 908
4. L. Campeau Lipid lowering and coronary bypass graft surgery Curr Opin Cardiol 15 2000 395 399
5. D.S. Souza, M.R. Dashwood, J.C. Tsui, D. Filbey, L. Bodin, B. Johansson, and J. Borowiec Improved patency in vein grafts harvested with surrounding tissue: results of a randomized study using three harvesting techniques Ann Thorac Surg 73 2002 1189 1195
6. J.Y. Jeremy, N. Shukla, S. Muzaffar, and G.D. Angelini Reactive oxygen species, vascular disease and cardiovascular surgery Curr Vasc Pharmacol 2 2004 229 236
7. J.Y. Jeremy, C.L. Jackson, A.J. Bryan, and G.D. Angelini Eicosanoids, fatty acids and restenosis following coronary artery bypass graft surgery and balloon angioplasty Prostaglandins Leukot Essent Fatty Acids 54 1996 385 402
8. J.Y. Jeremy, D. Mehta, A.J. Bryan, and G.D. Angelini Platelets and saphenous vein graft failure Platelets 8 1997 295 309
9. A.C. Newby Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture Physiol Rev 85 2005 1 31
10. J.Y. Jeremy, M.B. Izzat, S.D. Birkett, D.M. Knight, A.J. Bryan, and G.D. Angelini Reduced prostacyclin and increased leukotriene B4 synthesis in porcine vein grafts Ann Thorac Surg 61 1996 143 148
11. J.Y. Jeremy, M. Dashwood, M. Timm, M.B. Izzat, D. Mehta, A.J. Bryan, and G.D. Angelini Nitric oxide synthase and cyclic nucleotide synthesis by porcine venous-arterial grafts Ann Thorac Surg 63 1997 470 476
12. J.Y. Jeremy, M.R. Dashwood, D. Mehta, M.B. Izzat, N. Shukla, and G.D. Angelini Nitric oxide synthase, prostacyclin and cyclic nucleotide production in externally stented porcine vein grafts Atherosclerosis 141 1998 297 305
13. A. Ehsan, M.J. Mann, G. Dell'Acqua, and V.J. Dzau Endothelial healing in vein grafts: proliferative burst unimpaired by genetic therapy of neointimal disease Circulation 105 2002 1686 1692
14. H.S. Thatte, and S.F. Khuri The coronary artery bypass conduit. I. Intraoperative endothelial injury and its implication on graft patency Ann Thorac Surg 72 2001 S2245 S2252
15. C. Caro, J.Y. Jeremy, N. Watkins, R. Bulbulia, G. Angelini, F. Smith, S. Wan, A. Yim, S. Sherwin, and J. Peiró Geometry of unstented and stented pig common carotid artery bypass grafts Biorheology 39 2002 507 512
16. J.Y. Jeremy, A.P. Yim, S. Wan, and G.D. Angelini Oxidative stress, nitric oxide and vascular disease Cardiovasc Surg 17 2002 324 327
17. J.Y. Jeremy, D. Rowe, A.M. Emsley, and A.C. Newby Nitric oxide and vascular smooth muscle cell proliferation Cardiovasc Res 43 1999 580 594
18. S. Muzaffar, J.Y. Jeremy, G.D. Angelini, and N. Shukla The role of the endothelium and nitric oxide synthases in modulating superoxide formation induced by endotoxin and cytokines in porcine pulmonary arteries Thorax 58 2003 598 604
19. 2α in cultured porcine pulmonary artery vascular smooth muscle cells Br J Pharmacol 141 2004 488 496
20. S. Muzaffar, N. Shukla, G.D. Angelini, and J.Y. Jeremy Nitroaspirins and SIN-1, but not aspirin, inhibit the expression of endotoxin- and cytokine-induced NAPDH oxidase in vascular smooth muscle cells from pig pulmonary arteries Circulation 110 2004 1140 1147
21. phox and endothelial nitric oxide synthase in the pulmonary artery Thorax 60 2005 305 313
22. L. Campeau, M. Enjalbert, J. Lespérance, M.G. Bourassa, P. Kwiterovich Jr., S. Wacholder, and A. Sniderman The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery N Engl J Med 311 1984 1329 1332
23. J. Bucerius, J.F. Gummert, T. Walther, N. Doll, V. Falk, and J.F. Onnasch Impact of diabetes mellitus on cardiac surgery outcome J Thorac Cardiovasc Surg 51 2003 11 16
24. T. Alserius, N. Hammar, T. Nordqvist, and T. Ivert Risk of death or acute myocardial infarction 10 years after coronary artery bypass surgery in relation to type of diabetes Am Heart J 152 2006 599 605
25. T. Hakala, O. Pitkanen, P. Halonen, J. Mustonen, A. Turpeinen, and M. Hippelainen Early and late outcome after coronary artery bypass surgery in diabetic patients Scand Cardiovasc J 39 2005 177 181
26. J. Bloor, N. Shukla, F.C.T. Smith, G.D. Angelini, and J.Y. Jeremy Folic acid administration reduces neointimal thickening, augments neo vasa vasorum formation and reduces oxidative stress in saphenous vein grafts from diabetic pigs Diabetologia 53 2010 980 988
27. M.R. Dashwood, K. Savage, J.C. Tsui, A. Dooley, S.G. Shaw, M.S. Fernández Alfonso, L. Bodin, and D.S. Souza Retaining perivascular tissue of human saphenous vein grafts protects against surgical and distension-induced damage and preserves endothelial nitric oxide synthase and nitric oxide synthase activity J Thorac Cardiovasc Surg 138 2009 334 340
28. D.S. Souza, B. Johansson, L. Bojo, R. Karlsson, H. Geijer, D. Filbey, L. Bodin, M. Arbeus, and M.R. Dashwood Harvesting the saphenous vein with surrounding tissue for CABG provides long-term graft patency comparable to the left internal thoracic artery: results of a randomized longitudinal trial J Thorac Cardiovasc Surg 132 2006 373 378
29. M.S. Suleiman, K. Zacharowski, and G.D. Angelini Inflammatory response and cardioprotection during open-heart surgery: the importance of anaesthetics Br J Pharmacol 153 2008 21 33
30. C. Cheng, D. Bainbridge, J.E. Martin, and R.J. Novick Evidence based perioperative clinical outcomes research group. Does off-pump coronary artery bypass reduce mortality, morbidity, and resource utilization when compared with conventional coronary artery bypass? A meta-analysis of randomized trials Anesthesiology 102 2005 188 203
31. N.E. Khan, A. De Souza, R. Mister, M. Flather, J. Clague, S. Davies, P. Collins, D. Wang, U. Sigwart, and J. Pepper A randomized comparison of off-pump and on-pump multivessel coronary-artery bypass surgery N Engl J Med 350 2004 21 28
32. P. Parang, and R. Arora Coronary vein graft disease: pathogenesis and prevention Can J Cardiol 25 2009 e57 e62
33. E.S. Brilakis, B. Saeed, and S. Banerjee Drug-eluting stents in saphenous vein graft interventions: a systematic review EuroIntervention 5 2010 722 730
34. D. Mehta, S.J. George, J.Y. Jeremy, A.J. Bryan, A.C. Newby, and G.D. Angelini External stenting reduces long-term medial and neointimal thickening in a pig model of arteriovenous bypass grafting Nat Med 4 1998 235 239
35. J.Y. Jeremy, R. Bulbulia, V. Vijayan, J.L. Johnson, P. Gadsdon, and G.D. Angelini A bioabsorbable external stent inhibits porcine saphenous vein graft thickening J Thorac Cardiovasc Surg 127 2004 1766 1772
36. V. Vijayan, N. Shukla, J.L. Johnson, and J.Y. Jeremy Long-term reduction of medial and intimal thickening in porcine saphenous vein grafts with a polyglactin biodegradable external sheath J Vasc Surg 40 2004 1011 1019
37. G.J. Murphy, A.C. Newby, J.Y. Jeremy, A. Baumbach, and G.D. Angelini A randomized trial of an external Dacron sheath for the prevention of vein graft disease: the extent study J Thorac Cardiovasc Surg 134 2007 504 505
38. J.Y. Jeremy, and A.C. Thomas Animal models for studying neointima formation and its consequences Curr Vasc Pharmacol 8 2010 198 219
39. T. Schachner, Y. Zou, A. Oberhuber, A. Tzankov, T. Mairinger, G. Laufer, and J.O. Bonatti Local application of rapamycin inhibits neointimal hyperplasia in experimental vein grafts Ann Thorac Surg 77 2004 1580 1585
40. G.J. Murphy, T.W. Johnson, M.H. Chamberlain, I. Rizvi, M. Wyatt, S.J. George, G.D. Angelini, K.R. Karsch, M. Oberhoff, and A.C. Newby Short- and long-term effects of cytochalasin D, paclitaxel and rapamycin on wall thickening in experimental porcine vein grafts Cardiovasc Res 73 2007 607 617
41. A. Kulik, and M. Ruel Statins and coronary artery bypass graft surgery: preoperative and postoperative efficacy and safety Expert Opin Drug Saf 8 2009 559 571
42. N. Shukla, G.D. Angelini, I. Wan, and J.Y. Jeremy Potential role of nitroaspirins in the treatment of vein graft failure Ann Thorac Surg 75 2003 1437 1442
43. S. Wan, A. Yim, N. Shukla, J.L. Johnson, G.D. Angelini, and J.Y. Jeremy Nitric oxide donating aspirin (NCX 4016) inhibits neointimal thickening in a pig model of saphenous vein into carotid artery interposition grafting: a comparison with aspirin and morpholinosydnonimine J Thorac Cardiovasc Surg 134 2007 1033 1039
44. A. Sparatore, E. Perrino, V. Tazzari, D. Giustarini, R. Rossi, G. Rossoni, K. Erdman, H. Henning Schröder, and P. Piero Del Soldato Pharmacological profile of a novel H2S-releasing aspirin Free Radic Biol Med 46 2009 586 592
45. A receptor antagonist, BSF 302146, is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein-carotid artery interposition grafts J Thorac Cardiovasc Surg 127 2004 1317 1322
46. G.J. Fulton, M.G. Davies, and L. Barber Localized versus systemic angiotensin II receptor inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor L158,809 Surgery 123 1998 218 227
47. K.E. Porter, I.M. Loftus, and M. Peterson Marimastat inhibits neointimal thickening in a model of human vein graft stenosis Br J Surg 85 1998 1373 1377
48. S. Muzaffar, N. Shukla, C. Lobo, G.D. Angelini, and J.Y. Jeremy Nicotinamide adenine dinucleotide phosphate oxidase: a promiscuous therapeutic target for cardiovascular drugs? Trends Cardiovasc Med 15 2005 278 282
49. J.Y. Jeremy, S.J. George, M. Wyatt, N. Shukla, J. Bloor, A.C. Newby, and G.D. Angelini Toward the prevention of vein graft failure C. Handler, D. Abraham, G. Coghlan, M. Dashwood, Vascular Complications in Human Disease: Mechanisms and Consequences 2007 Elsevier (pub) 345 368
50. S. Wan, A. Yim, G.D. Angelini, and J.Y. Jeremy Novel Strategies for the prevention of vein graft failure H. Guo Wei, Arterial Grafting for Coronary Artery Bypass Surgery: A Textbook for Cardiovascular Clinicians and Researchers 2007 Elsevier (pub) 303 309